简介内容:XR8-89, a potent inhibitor of papain-like protease (PLpro), exhibits an IC50 value of μM and effectively hinders SARS-CoV-2 replication by inducing conformational changes in the SARS-COV-2 papain-like protease. This compound holds potential for SARS-CoV-2 research applications [1].